Positions

Research Overview

  • BK infections in kidney transplant patients
    Alternative immunosuppression regimens for rapid metabolizers
    Skin cancer in kidney transplant patients

    • Principal Investigator On

  • Private Grant  awarded by VELOXIS PHARMACEUTICALS A/S 2019 - 2023

    • Investigator On

  • Private Grant  awarded by CSL BEHRING, LLC 2017 - 2022
  • APOL1 Long-Term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2019 - 2022
  • Private Grant  awarded by MALLINCKRODT, INC. 2017 - 2022
  • Private Grant  awarded by TRANSPLANT GENOMICS, INC. 2020 - 2021
  • Private Grant  awarded by ASTELLAS PHARMA US, INC. 2017 - 2021
  • Private Grant  awarded by CAREDX INC. 2015 - 2020
  • Effects of Inhibiting Early Inflammation in Kidney Transplant Patients  awarded by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI 2019 - 2020
  • Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts  awarded by University of California, San Francisco 2019 - 2020
  • Private Grant  awarded by TRANSPLANT GENOMICS, INC. 2017 - 2019
  • Private Grant  awarded by ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC. - NEW 2018 - 2019
  • Effects of Inhibiting Early Inflammation in Kidney Transplant Patients - Equipment  awarded by Mount Sinai School of Medicine 2015 - 2019
  • Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts  awarded by University of California, San Francisco 2014 - 2019
  • Private Grant  awarded by QUARK PHARMACEUTICALS, INC. 2015 - 2019
  • Private Grant  awarded by CINKATE CORPORATION 2012 - 2018
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2015 - 2018
  • Private Grant  awarded by ASTELLAS PHARMA US, INC. 2013 - 2017
  • Using Microarrays to Assess Transplant Biopsies: The Future Standard of Care (INTERCOMEX: The INTERCOM Extension Study)  awarded by University of Alberta at Edmonton 2015 - 2017
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC. 2014 - 2017
  • Preserving Renal Function & Protective Immunity via Anti-LFA-1-Based CNI Avoidance  awarded by Emory University 2009 - 2016
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC. 2013 - 2016
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2013 - 2016

    • Education And Training

  • Doctor of Medicine, University of Texas System : Medical Branch 2006
  • Baylor College of Medicine, Residency 2009
  • Vanderbilt University Medical Center, Postdoctoral Fellowship 2012
  • Baylor College of Medicine, Postdoctoral Fellowship 2011

    • Full Name

  • Graham Towns